Structure

Physi-Chem Properties

Molecular Weight:  426.2
Volume:  446.936
LogP:  5.164
LogD:  4.172
LogS:  -4.927
# Rotatable Bonds:  8
TPSA:  85.97
# H-Bond Aceptor:  6
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.276
Synthetic Accessibility Score:  4.22
Fsp3:  0.44
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.75
MDCK Permeability:  2.1341247702366672e-05
Pgp-inhibitor:  0.164
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.119
30% Bioavailability (F30%):  0.927

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.069
Plasma Protein Binding (PPB):  96.23609161376953%
Volume Distribution (VD):  0.321
Pgp-substrate:  1.243890404701233%

ADMET: Metabolism

CYP1A2-inhibitor:  0.522
CYP1A2-substrate:  0.899
CYP2C19-inhibitor:  0.937
CYP2C19-substrate:  0.505
CYP2C9-inhibitor:  0.901
CYP2C9-substrate:  0.922
CYP2D6-inhibitor:  0.831
CYP2D6-substrate:  0.886
CYP3A4-inhibitor:  0.929
CYP3A4-substrate:  0.415

ADMET: Excretion

Clearance (CL):  6.12
Half-life (T1/2):  0.211

ADMET: Toxicity

hERG Blockers:  0.051
Human Hepatotoxicity (H-HT):  0.929
Drug-inuced Liver Injury (DILI):  0.851
AMES Toxicity:  0.013
Rat Oral Acute Toxicity:  0.668
Maximum Recommended Daily Dose:  0.095
Skin Sensitization:  0.179
Carcinogencity:  0.03
Eye Corrosion:  0.003
Eye Irritation:  0.016
Respiratory Toxicity:  0.35

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474542

Natural Product ID:  NPC474542
Common Name*:   Fukanedone E
IUPAC Name:   (3S,4R,5R)-3-(2-hydroxy-4-methoxybenzoyl)-4,5-dimethyl-5-[(E)-4-methyl-5-(4-methylfuran-2-yl)pent-3-enyl]oxolan-2-one
Synonyms:   fukanedone E
Standard InCHIKey:  LHLJDPNWUZLDDY-YFWWFAMISA-N
Standard InCHI:  InChI=1S/C25H30O6/c1-15(11-19-12-16(2)14-30-19)7-6-10-25(4)17(3)22(24(28)31-25)23(27)20-9-8-18(29-5)13-21(20)26/h7-9,12-14,17,22,26H,6,10-11H2,1-5H3/b15-7+/t17-,22+,25-/m1/s1
SMILES:  COc1ccc(c(c1)O)C(=O)[C@H]1C(=O)O[C@]([C@@H]1C)(C)CC/C=C(/Cc1occ(c1)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL471594
PubChem CID:   21593959
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0001831] Carbonyl compounds
          • [CHEMONTID:0000118] Ketones
            • [CHEMONTID:0003670] Aryl ketones
              • [CHEMONTID:0004296] Phenylketones
                • [CHEMONTID:0004298] Alkyl-phenylketones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. root n.a. PMID[15043424]
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[15043424]
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. root n.a. PMID[15467238]
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[15787437]
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[16378364]
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3780 Ferula fukanensis Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 76200.0 nM PMID[497537]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474542 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9145 High Similarity NPC156244
0.9097 High Similarity NPC296957
0.9097 High Similarity NPC260902
0.9085 High Similarity NPC67654
0.9032 High Similarity NPC247677
0.9032 High Similarity NPC160015
0.8974 High Similarity NPC269495
0.8974 High Similarity NPC270044
0.8917 High Similarity NPC476349
0.8917 High Similarity NPC476350
0.8917 High Similarity NPC40583
0.8889 High Similarity NPC120220
0.8874 High Similarity NPC230943
0.8861 High Similarity NPC115432
0.8861 High Similarity NPC49009
0.8861 High Similarity NPC260296
0.8844 High Similarity NPC187826
0.8834 High Similarity NPC472584
0.8831 High Similarity NPC191104
0.8831 High Similarity NPC155882
0.8824 High Similarity NPC135325
0.8816 High Similarity NPC299011
0.8812 High Similarity NPC155640
0.8812 High Similarity NPC91288
0.8808 High Similarity NPC302181
0.8805 High Similarity NPC14822
0.8797 High Similarity NPC244750
0.8782 High Similarity NPC122365
0.8782 High Similarity NPC213608
0.8782 High Similarity NPC1477
0.8776 High Similarity NPC474726
0.8776 High Similarity NPC475955
0.8766 High Similarity NPC226644
0.8766 High Similarity NPC88445
0.8766 High Similarity NPC37226
0.8766 High Similarity NPC296030
0.8766 High Similarity NPC39929
0.8765 High Similarity NPC320789
0.8758 High Similarity NPC136641
0.8758 High Similarity NPC130581
0.8758 High Similarity NPC12148
0.875 High Similarity NPC316535
0.875 High Similarity NPC184649
0.875 High Similarity NPC303185
0.875 High Similarity NPC311144
0.8742 High Similarity NPC202981
0.8742 High Similarity NPC53192
0.8742 High Similarity NPC95472
0.8742 High Similarity NPC239270
0.8742 High Similarity NPC303210
0.8742 High Similarity NPC169
0.8734 High Similarity NPC65504
0.8725 High Similarity NPC124269
0.8718 High Similarity NPC207624
0.8718 High Similarity NPC5871
0.8718 High Similarity NPC41326
0.8718 High Similarity NPC263676
0.8707 High Similarity NPC236974
0.8707 High Similarity NPC144027
0.8704 High Similarity NPC323137
0.8701 High Similarity NPC39195
0.8693 High Similarity NPC300267
0.8693 High Similarity NPC477955
0.8693 High Similarity NPC210826
0.8693 High Similarity NPC51641
0.8688 High Similarity NPC304387
0.8688 High Similarity NPC92589
0.8684 High Similarity NPC113770
0.8658 High Similarity NPC188879
0.8654 High Similarity NPC58668
0.8654 High Similarity NPC193976
0.8654 High Similarity NPC23668
0.8654 High Similarity NPC290671
0.8654 High Similarity NPC170169
0.8654 High Similarity NPC116604
0.8654 High Similarity NPC115324
0.8654 High Similarity NPC106372
0.865 High Similarity NPC476459
0.8645 High Similarity NPC221868
0.8645 High Similarity NPC37208
0.8645 High Similarity NPC317492
0.8642 High Similarity NPC329215
0.8642 High Similarity NPC204088
0.8642 High Similarity NPC259007
0.8636 High Similarity NPC113428
0.8636 High Similarity NPC304443
0.8636 High Similarity NPC61284
0.8636 High Similarity NPC74539
0.8636 High Similarity NPC17816
0.8636 High Similarity NPC308200
0.8627 High Similarity NPC271288
0.8627 High Similarity NPC469953
0.8627 High Similarity NPC311741
0.8627 High Similarity NPC234629
0.8625 High Similarity NPC304839
0.8625 High Similarity NPC220582
0.8618 High Similarity NPC472006
0.8609 High Similarity NPC16455
0.8609 High Similarity NPC307990
0.8609 High Similarity NPC284550
0.8609 High Similarity NPC129853
0.8609 High Similarity NPC76445
0.8608 High Similarity NPC148938
0.8608 High Similarity NPC198490
0.8608 High Similarity NPC99199
0.86 High Similarity NPC470399
0.8599 High Similarity NPC142308
0.8591 High Similarity NPC213603
0.8591 High Similarity NPC470397
0.8591 High Similarity NPC470398
0.8591 High Similarity NPC156910
0.8591 High Similarity NPC240593
0.859 High Similarity NPC167576
0.859 High Similarity NPC29777
0.859 High Similarity NPC471115
0.859 High Similarity NPC472406
0.859 High Similarity NPC472421
0.859 High Similarity NPC230713
0.859 High Similarity NPC78335
0.8589 High Similarity NPC53640
0.8581 High Similarity NPC168085
0.8581 High Similarity NPC272194
0.8581 High Similarity NPC145467
0.8581 High Similarity NPC266572
0.8581 High Similarity NPC266743
0.858 High Similarity NPC109180
0.858 High Similarity NPC471286
0.8571 High Similarity NPC470322
0.8571 High Similarity NPC154217
0.8571 High Similarity NPC25844
0.8571 High Similarity NPC308799
0.8571 High Similarity NPC203817
0.8571 High Similarity NPC472033
0.8562 High Similarity NPC472877
0.8562 High Similarity NPC131043
0.8562 High Similarity NPC105381
0.8562 High Similarity NPC473976
0.8562 High Similarity NPC109812
0.8562 High Similarity NPC106985
0.8562 High Similarity NPC225884
0.8562 High Similarity NPC313039
0.8562 High Similarity NPC198459
0.8562 High Similarity NPC10302
0.8562 High Similarity NPC166138
0.8562 High Similarity NPC18585
0.8553 High Similarity NPC109967
0.8553 High Similarity NPC129053
0.8553 High Similarity NPC321372
0.8553 High Similarity NPC469936
0.8553 High Similarity NPC470625
0.8553 High Similarity NPC78554
0.8553 High Similarity NPC474609
0.8553 High Similarity NPC474738
0.8553 High Similarity NPC13879
0.8553 High Similarity NPC475797
0.8553 High Similarity NPC171870
0.8544 High Similarity NPC183874
0.8544 High Similarity NPC131725
0.8544 High Similarity NPC72370
0.8544 High Similarity NPC235333
0.8544 High Similarity NPC42458
0.8544 High Similarity NPC158261
0.8544 High Similarity NPC472462
0.8543 High Similarity NPC37206
0.8543 High Similarity NPC261234
0.8543 High Similarity NPC316480
0.8543 High Similarity NPC477956
0.8543 High Similarity NPC137009
0.8543 High Similarity NPC23257
0.8535 High Similarity NPC316960
0.8535 High Similarity NPC474744
0.8535 High Similarity NPC148945
0.8535 High Similarity NPC318424
0.8535 High Similarity NPC474772
0.8535 High Similarity NPC472423
0.8535 High Similarity NPC317715
0.8535 High Similarity NPC78835
0.8535 High Similarity NPC209142
0.8535 High Similarity NPC312549
0.8535 High Similarity NPC204561
0.8535 High Similarity NPC309512
0.8535 High Similarity NPC471229
0.8535 High Similarity NPC472580
0.8528 High Similarity NPC291110
0.8526 High Similarity NPC164205
0.8526 High Similarity NPC473016
0.8526 High Similarity NPC471114
0.8526 High Similarity NPC104236
0.8526 High Similarity NPC214493
0.8526 High Similarity NPC178202
0.8516 High Similarity NPC97716
0.8516 High Similarity NPC237635
0.8516 High Similarity NPC79469
0.8516 High Similarity NPC201731
0.8516 High Similarity NPC24673
0.8516 High Similarity NPC104406
0.8506 High Similarity NPC196137
0.8506 High Similarity NPC1886
0.8506 High Similarity NPC209040
0.8506 High Similarity NPC472034

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474542 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8636 High Similarity NPD920 Approved
0.8616 High Similarity NPD3749 Approved
0.8506 High Similarity NPD642 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8355 Intermediate Similarity NPD1549 Phase 2
0.8344 Intermediate Similarity NPD1551 Phase 2
0.8323 Intermediate Similarity NPD6799 Approved
0.8313 Intermediate Similarity NPD7819 Suspended
0.8302 Intermediate Similarity NPD7411 Suspended
0.8301 Intermediate Similarity NPD1243 Approved
0.8289 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD2344 Approved
0.8278 Intermediate Similarity NPD1510 Phase 2
0.8272 Intermediate Similarity NPD7075 Discontinued
0.8269 Intermediate Similarity NPD2534 Approved
0.8269 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD2532 Approved
0.8269 Intermediate Similarity NPD2533 Approved
0.8255 Intermediate Similarity NPD1240 Approved
0.8239 Intermediate Similarity NPD6599 Discontinued
0.8235 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8224 Intermediate Similarity NPD2796 Approved
0.821 Intermediate Similarity NPD3882 Suspended
0.8199 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD2800 Approved
0.8153 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8146 Intermediate Similarity NPD1607 Approved
0.8129 Intermediate Similarity NPD3750 Approved
0.811 Intermediate Similarity NPD919 Approved
0.8098 Intermediate Similarity NPD7768 Phase 2
0.8084 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8077 Intermediate Similarity NPD2309 Approved
0.8039 Intermediate Similarity NPD2799 Discontinued
0.8025 Intermediate Similarity NPD6801 Discontinued
0.8013 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD1934 Approved
0.7901 Intermediate Similarity NPD4380 Phase 2
0.7882 Intermediate Similarity NPD3818 Discontinued
0.7866 Intermediate Similarity NPD2801 Approved
0.7849 Intermediate Similarity NPD5953 Discontinued
0.7844 Intermediate Similarity NPD5494 Approved
0.7818 Intermediate Similarity NPD3817 Phase 2
0.7811 Intermediate Similarity NPD3926 Phase 2
0.7806 Intermediate Similarity NPD3748 Approved
0.7798 Intermediate Similarity NPD1247 Approved
0.7785 Intermediate Similarity NPD4628 Phase 3
0.7771 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD2935 Discontinued
0.775 Intermediate Similarity NPD1511 Approved
0.7733 Intermediate Similarity NPD7286 Phase 2
0.7719 Intermediate Similarity NPD7473 Discontinued
0.7716 Intermediate Similarity NPD5403 Approved
0.7703 Intermediate Similarity NPD9717 Approved
0.7684 Intermediate Similarity NPD8434 Phase 2
0.7677 Intermediate Similarity NPD6651 Approved
0.7673 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD1203 Approved
0.7657 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD1512 Approved
0.7647 Intermediate Similarity NPD6232 Discontinued
0.7632 Intermediate Similarity NPD6832 Phase 2
0.7605 Intermediate Similarity NPD5402 Approved
0.7598 Intermediate Similarity NPD4287 Approved
0.7593 Intermediate Similarity NPD5401 Approved
0.7588 Intermediate Similarity NPD6959 Discontinued
0.758 Intermediate Similarity NPD7033 Discontinued
0.7572 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD6166 Phase 2
0.7558 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD5761 Phase 2
0.7545 Intermediate Similarity NPD5760 Phase 2
0.7544 Intermediate Similarity NPD5710 Approved
0.7544 Intermediate Similarity NPD6808 Phase 2
0.7544 Intermediate Similarity NPD5711 Approved
0.7532 Intermediate Similarity NPD3764 Approved
0.7532 Intermediate Similarity NPD2313 Discontinued
0.7532 Intermediate Similarity NPD3268 Approved
0.7529 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD3226 Approved
0.75 Intermediate Similarity NPD2296 Approved
0.75 Intermediate Similarity NPD230 Phase 1
0.7486 Intermediate Similarity NPD7074 Phase 3
0.7483 Intermediate Similarity NPD9545 Approved
0.7458 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD2797 Approved
0.7429 Intermediate Similarity NPD7054 Approved
0.7429 Intermediate Similarity NPD5844 Phase 1
0.7421 Intermediate Similarity NPD6099 Approved
0.7421 Intermediate Similarity NPD6100 Approved
0.7403 Intermediate Similarity NPD4908 Phase 1
0.74 Intermediate Similarity NPD422 Phase 1
0.7394 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD2654 Approved
0.7389 Intermediate Similarity NPD447 Suspended
0.7386 Intermediate Similarity NPD2798 Approved
0.7386 Intermediate Similarity NPD1729 Discontinued
0.7386 Intermediate Similarity NPD7472 Approved
0.7384 Intermediate Similarity NPD7199 Phase 2
0.7381 Intermediate Similarity NPD6280 Approved
0.7381 Intermediate Similarity NPD6279 Approved
0.7378 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD6005 Phase 3
0.7375 Intermediate Similarity NPD1471 Phase 3
0.7375 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD6002 Phase 3
0.7375 Intermediate Similarity NPD6004 Phase 3
0.7375 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD2346 Discontinued
0.7368 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD4308 Phase 3
0.7351 Intermediate Similarity NPD1608 Approved
0.7347 Intermediate Similarity NPD9493 Approved
0.7345 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD6797 Phase 2
0.7341 Intermediate Similarity NPD7229 Phase 3
0.7337 Intermediate Similarity NPD1465 Phase 2
0.7325 Intermediate Similarity NPD943 Approved
0.7308 Intermediate Similarity NPD411 Approved
0.7308 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD7251 Discontinued
0.7299 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD1610 Phase 2
0.7278 Intermediate Similarity NPD5124 Phase 1
0.7278 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6355 Discontinued
0.7278 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD1019 Discontinued
0.7267 Intermediate Similarity NPD6234 Discontinued
0.7263 Intermediate Similarity NPD7808 Phase 3
0.7257 Intermediate Similarity NPD2403 Approved
0.7251 Intermediate Similarity NPD4967 Phase 2
0.7251 Intermediate Similarity NPD4965 Approved
0.7251 Intermediate Similarity NPD4966 Approved
0.725 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD3267 Approved
0.7208 Intermediate Similarity NPD3266 Approved
0.7207 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD4361 Phase 2
0.7202 Intermediate Similarity NPD7458 Discontinued
0.7193 Intermediate Similarity NPD4288 Approved
0.7171 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD17 Approved
0.7143 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD3972 Approved
0.7107 Intermediate Similarity NPD4307 Phase 2
0.7101 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1296 Phase 2
0.7076 Intermediate Similarity NPD37 Approved
0.7074 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1933 Approved
0.7059 Intermediate Similarity NPD4363 Phase 3
0.7059 Intermediate Similarity NPD4360 Phase 2
0.7051 Intermediate Similarity NPD5647 Approved
0.7037 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD8312 Approved
0.7033 Intermediate Similarity NPD8313 Approved
0.7032 Intermediate Similarity NPD1876 Approved
0.7032 Intermediate Similarity NPD3225 Approved
0.703 Intermediate Similarity NPD7003 Approved
0.7024 Intermediate Similarity NPD6273 Approved
0.702 Intermediate Similarity NPD1548 Phase 1
0.7017 Intermediate Similarity NPD6764 Approved
0.7017 Intermediate Similarity NPD6765 Approved
0.7006 Intermediate Similarity NPD9494 Approved
0.6988 Remote Similarity NPD3887 Approved
0.6988 Remote Similarity NPD2354 Approved
0.6987 Remote Similarity NPD1164 Approved
0.6983 Remote Similarity NPD7228 Approved
0.6983 Remote Similarity NPD3751 Discontinued
0.6981 Remote Similarity NPD6798 Discontinued
0.6968 Remote Similarity NPD4749 Approved
0.6928 Remote Similarity NPD1778 Approved
0.6923 Remote Similarity NPD6104 Discontinued
0.6914 Remote Similarity NPD6971 Discontinued
0.6913 Remote Similarity NPD1241 Discontinued
0.691 Remote Similarity NPD5242 Approved
0.6905 Remote Similarity NPD7390 Discontinued
0.6894 Remote Similarity NPD4060 Phase 1
0.689 Remote Similarity NPD5404 Approved
0.689 Remote Similarity NPD4477 Approved
0.689 Remote Similarity NPD5408 Approved
0.689 Remote Similarity NPD5406 Approved
0.689 Remote Similarity NPD4476 Approved
0.689 Remote Similarity NPD5405 Approved
0.6875 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6875 Remote Similarity NPD1699 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data